Cancer BiologybioRxivPreprint
A stromal metabolic program suppresses NK-cell immunity to drive tumor progression in HER2-low breast cancer
Kayla Carter, Olajumoke Ogunlusi, Mrinmoy Sarkar…·Tapasree Roy Sarkar
This study identifies a stromal metabolic program in HER2-low breast cancer that suppresses NK-cell immunity, promoting tumor progression through BCAT1-dependent BCKA production.
DOI 10.64898/2026.09.07.749862